The Future of Ketamine and Mood Disorders In 2019, the FDA and European Commission approved the usage of an esketamine nasal spready underneath the brand name Spravato to deal with melancholy. On the other hand, as of 2021, ketamine has not been permitted by the FDA to deal with melancholy https://lloydx852ilm1.qodsblog.com/profile